Nebivolol as a first-line antihypertensive: a justifiable proposal?: Table 1
10.1136/heartasia-2016-010728
Saved in:
Main Authors: | Ling, Lieng H, Oh, Vernon MS |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
BMJ
2022
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/228038 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Nebivolol as a first-line antihypertensive: a justifiable proposal?
by: Oh, Min Sen Vernon
Published: (2022) -
Metabolic effects of antihypertensive drugs
by: Oh, V.M.S.
Published: (2016) -
Antihypertensive effect of BS 100-141, a new central acting antihypertensive agent
by: Somchart Lochaya, et al.
Published: (2018) -
Protection: Risk ratio of antihypertensive drug treatment in the elderly
by: Oh, V.M.S.
Published: (2016) -
Are Political Apologies Justified?
by: ALDO DENNIS C. JOSON
Published: (2011)